RADICAVA® has been shown to result in 33% less decline in physical function vs placebo as measured by the ALSFRS-R.
FDA recognizes RADICAVA ORS® as MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.
FDA recognizes RADICAVA ORS® as MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.
Built on Solid Ground
RADICAVA ORS® (edaravone) is an ORAL administration option of RADICAVA® (edaravone), an ALS treatment shown to slow the loss of physical function.
RADICAVA ORS® was recognized by the FDA in 2024 for its Major Contribution to Patient Care
16,400+ people have been treated with RADICAVA® since 2017 for 2.0 million+ days of therapya,b (see footnote)
RADICAVA ORS® was FDA-approved in 2022 and offers the same drug as RADICAVA®
in an oral formulation
How Treatment Can Help
Taking Treatment Orally
RADICAVA ORS® 5 mL dose may take only a few minutes to administer on treatment days. c,d (see footnote)
Getting Started
Review steps about starting RADICAVA®. Learn about financial support options.
For Your Moments Big and Small
RADICAVA ORS® can fit your life’s routines with a 5 mL oral dose of a proven treatment. ALS can progress rapidly. Beginning treatment with RADICAVA ORS® can be an important step to managing your ALS.
Talk to your doctor about RADICAVA ORS®.
DISCOVER RADICAVA ORS®No matter where you are in your ALS journey—from diagnosis to treatment—the JourneyMate Support Program™ gives you the understanding, answers, and resources to help you move forward.
If you’re new to treatment, the program can help you learn more about RADICAVA®. If you’re currently using RADICAVA® IV, the program can help you learn more about switching to RADICAVA ORS®.
The RADICAVA® Educational Communications Series—Sign Up Today
Join our community of 18,000+ people who’ve signed up to learn more about RADICAVA ORS® or RADICAVA® IV and why it matters to patients and caregivers.
Help other people living with ALS by sharing your experience with ALS and RADICAVA®. See how you can share
ALS=amyotrophic lateral sclerosis; IV=intravenous.
aBased on RADICAVA ORS® and RADICAVA® IV prescriptions submitted in the US as of August 2024. Not independently verified. Return to content
bDays of therapy based on number of RADICAVA ORS® and RADICAVA® IV cartons sold as of August 2024. Each carton of RADICAVA® IV includes 1 day of therapy. For RADICAVA ORS®, each Starter Kit includes 14 days of therapy, and each Maintenance Kit includes 10 days of therapy. Return to content
cThe initial treatment cycle starts with daily dosing of RADICAVA ORS® for 14 days followed by a 14-day drug-free period. Subsequent treatment cycles include daily dosing 10 out of 14 days followed by a 14-day drug-free period. Return to content
dUse the provided 5 mL syringe that comes with the product. Do not use a household teaspoon to measure your medication. Return to content